Intense PET signal in the degenerative necrosis superimposed on chronic pancreatitis

Pancreas

Volumn 31, Issue 2, 2005, Pages 192-194

  Yokoyama, Yukihiro ^a   Nagino, Masato ^a   Hiromatsu, Takashi ^a   Yuasa, Norihiro ^a   Oda, Koji ^a   Arai, Toshiyuki ^a   Nishio, Hideki ^a   Ebata, Tomoki ^a   Nimura, Yuji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Computed tomography; Differential diagnosis; Standard uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMINAL PAIN; AGED; ARTICLE; CASE REPORT; CHRONIC PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; GRANULATION TISSUE; HUMAN; INFLAMMATION; MALE; MALIGNANT NEOPLASTIC DISEASE; PANCREAS CANCER; PANCREAS NECROSIS; PANCREATICODUODENECTOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; NECROSIS; PANCREAS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PANCREATITIS, CHRONIC; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 23044451279     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000168226.36085.58     Document Type: Article

References (10)

1. Koyama K, Okamura T, Kawabe J, et al. Diagnostic usefulness of FDG PET for pancreatic mass lesions. Ann Nucl Med. 2001;15:217-224.
2. Kasperk RK, Riesener KP, Wilms K, et al. Limited value of positron emission tomography in treatment of pancreatic cancer: surgeon's view. World J Surg. 2001;25:1134-1139.
3. Imdahl A, Nitzsche E, Krautmann F, et al. Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg. 1999;86:194-199.
4. Kato T, Fukatsu H, Ito K, et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem. Eur J Nucl Med. 1995;22:32-39.
5. Ho CL, Dehdashti F, Griffeth LK, et al. FDG-PET evaluation of indeterminate pancreatic masses. J Comput Assist Tomogr. 1996;20:363-369.
6. Zimny M, Bares R, Fass J, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases. Eur J Nucl Med. 1997;24:678-682.
7. Friess H, Langhans J, Ebert M, et al. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Gut. 1995;36:771-777.
8. Zimny M, Buell U. 18FDG-positron emission tomography in pancreatic cancer. Ann Oncol. 1999;10(Suppl 4):28-32.
9. Keogan MT, Tyler D, Clark L, et al. Diagnosis of pancreatic carcinoma: role of FDG PET. AJR Am J Roentgenol. 1998;171:1565-1570.
10. Sanabe N, Ikematsu Y, Nishiwaki Y, et al. Pancreatic tuberculosis. J Hepatobiliary Pancreat Surg. 2002;9:515-518.